We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
A picture of Blake Forman

Blake Forman profile page

Senior Science Writer

 at Technology Networks

Blake pens and edits breaking news, articles and features on a broad range of scientific topics with a focus on drug discovery and biopharma. Blake earned an honors degree in chemistry from the University of Surrey, which involved a placement year at the Medicines and Healthcare products Regulatory Agency (MHRA) laboratory, where he developed new pharmaceutical testing methods. Blake also holds an MSc in chemistry from the University of Southampton. His research project focused on the synthesis of novel fluorescent dyes often used as chemical/bio-sensors and as photosensitizers in photodynamic therapy. Blake held several editorial-based roles before joining Technology Networks in 2024.


Education

University of Surrey  

University of Southampton  


Areas of Expertise

Pharmacology
Pharmacovigilance
Analytical Chemistry
Mass Spectrometry
Drug Discovery
Science Communication

Got a Question for Blake Forman?

Get in touch using the contact form linked here and we'll get back to you shortly.



Content Written By, Reviewed By, or Featuring Blake Forman
Total: 158
Hand projecting a digital DNA helix with medical icons, symbolizing precision medicine technology.
Industry Insight

The Technology Start-Ups Hoping To Realize the Promise of Precision Medicine

Technology Networks asked a selection of start-up companies featured in the ELRIG Drug Discovery 2025 Breakthrough Zone how their technology could help realize the full capabilities of precision medicine.
Young scientists collaborating in a modern lab, researching for biotech start-up innovations.
Industry Insight

How Biotech Startups Are Redefining 3D Models and Sustainability in Drug Discovery

Explore how biotech start-ups are using 3D models and automation to reduce animal testing, cut waste and improve drug discovery outcomes.
A businessman in a suit handing out fanned $100 bills, symbolizing crowdfunding investment.
Industry Insight

How Crowdfunding Could Change the Cell and Gene Therapy Investor Landscape

Discover how crowdfunding could help biotech startups and cell and gene therapy developers overcome funding barriers by engaging patients, physicians and everyday investors.
A scientist holding a vial with a graphic of DNA, representing AAV quantification in gene therapy.
Industry Insight

Improving the Accessibility of AAV Quantification in Gene Therapy Development

Learn how the Amperia platform improves AAV quantification accuracy and speed, making gene therapy development more accessible and consistent.
The outline of a trophy against a blue background, representing the ELRIG Drug Discovery Innovation Award.
Industry Insight

Lipid-Free Cell Delivery System Wins ELRIG Drug Discovery 2025 Innovation Award

ELRIG Drug Discovery 2025 recognizes BubbleFect, a lipid-free cell delivery system that utilizes phase separation peptides for non-viral gene therapy delivery.
A gloved hand holding a pill next to test tubes containing blue liquid, representing proteomics in drug discovery.
Article

Applications of Proteomics in Drug Discovery

Explore how proteomics in drug discovery supports drug target identification, biomarker discovery and the unearthing of safer therapeutics.
A female doctor talking to a cancer patient receiving treatment in hospital.
Industry Insight

$3.4 Billion Acquisition To Bring Life-Changing Therapies to More Rare Tumor Patients

Discover how one of the biggest biopharma acquisitions of 2025 aims to expand rare tumor therapies for hard-to-treat cancers like desmoid tumors.
A scientist in a lab coat holding a hologram of a red and blue pill with a model of a molecule, representing AI in pharma.
Article

Pharma Is Embracing the Lab of the Future – Here’s How

Discover how artificial intelligence and automation are powering the lab of the future, revolutionizing pharma research and development and accelerating drug discovery worldwide.
A scientist holding up a vial containing a DNA double helix, representing cell and gene therapy manufacturing.
Industry Insight

FDA Delays Cell and Gene Therapy Approvals Following CMC Issues

Explore why cell and gene therapy manufacturing failures are now a leading cause of FDA rejections and how to avoid them.
A close up of a woman's eye, the target of a new stem cell therapy to treat blindness.
Industry Insight

A Stem Cell Therapy Resembling a Contact Lens Hopes To Cure Blindness

Stem cell therapy using iPSC technology on the surface of the eye could cure blindness by replacing damaged corneal cells – a new hope for vision restoration.
Advertisement
Advertisement
Advertisement
Decoratvive background images
Never miss a story
with the Breaking Science News daily newsletter